28TWENTYFOURSEVENBIOPHARMA Issue 3 / October 2025 NEWS On September 23rd, Merck and Siemens signed a Memorandum of Understanding extending their strategic partnership to accelerate digital transformation in the life sciences industry. The agreement centers on using digital-first solutions, including automation and AI, to close workflow gaps between drug discovery, development, and manufacturing. Before this agreement, the companies had also signed a prior MoU concerning smart manufacturing. Per the terms of the agreement, the companies plan to integrate Merck’s softwareas-a-service products with Siemens’ digital ecosystem. Merck’s AI tools and digital applications will be made available in Luma, Siemens’ Dotmatics Scientific Intelligence Platform. According to the press release, the intent of this is to provide a single environment linking product ordering with new digital tools, speeding up the process of making data-driven decisions. “Through this collaboration with Siemens, we are opening new possibilities for scientists to move faster from an idea in the lab to a therapy for patients,” said JeanCharles Wirth, Member of the Executive Board and CEO Life Science, Merck, in the press release. “By combining our strengths, we aim to change how science advances, unlocking new ways to accelerate scientific progress.” “We are partnering with Merck to give scientists around the world the instruments to speed up the development of life-saving medication,” said Cedrik Neike, Member of the Managing Board at Siemens AG and CEO of Siemens Digital Industries, in the press release. “Every few years the cost for developing a new drug is doubling. Data, AI and digitalization are key to break this paradigm. We are connecting every step of drug development through a digital backbone – so that data flows seamlessly, insights emerge faster, and medication reaches patients faster.” Merck and Siemens extend digital services partnership
RkJQdWJsaXNoZXIy MjY2OTA4MA==